湖南省湘中制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
100
NMPA:100
Drug Approvals
Vortioxetine Hydrobromide Tablets
- Product Name
- 氢溴酸伏硫西汀片
- Approval Number
- 国药准字H20254349
- Approval Date
- May 27, 2025
NMPA
Levetiracetam Oral Solution
- Product Name
- 左乙拉西坦口服溶液
- Approval Number
- 国药准字H20253467
- Approval Date
- Feb 25, 2025
NMPA
Sodium Valproate Sustained-release Tablets（Ⅰ）
- Product Name
- 丙戊酸钠缓释片(Ⅰ)
- Approval Number
- 国药准字H20249693
- Approval Date
- Dec 6, 2024
NMPA
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20249611
- Approval Date
- Dec 1, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found